Long-Term Extension Study of Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: HEADWAY-DLB Extension
Public ClinicalTrials.gov record NCT02928445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Long-Term Extension Study of the Safety and Tolerability of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Study identification
- NCT ID
- NCT02928445
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Axovant Sciences Ltd.
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- RVT-101 35 mg Drug
- RVT-101 70 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 86 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2016
- Primary completion
- Jan 31, 2018
- Completion
- Jan 31, 2018
- Last update posted
- Apr 17, 2018
2016 – 2018
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US138 | Phoenix | Arizona | 85006 | — |
| US108 | Phoenix | Arizona | 85013 | — |
| US139 | Sun City | Arizona | 85351 | — |
| US125 | Tucson | Arizona | 85704 | — |
| US119 | Orange | California | 92868 | — |
| US134 | Oxnard | California | 93030 | — |
| US133 | Rancho Mirage | California | 92270 | — |
| US140 | Sacramento | California | 95816 | — |
| US141 | Englewood | Colorado | 80113 | — |
| US123 | Washington D.C. | District of Columbia | 20007 | — |
| US104 | Boca Raton | Florida | 33431 | — |
| US111 | Jacksonville | Florida | 32224 | — |
| US122 | Orlando | Florida | 32806 | — |
| US137 | Palm Beach Gardens | Florida | 33410 | — |
| US126 | Tampa | Florida | 33609 | — |
| US136 | Atlanta | Georgia | 30331 | — |
| US118 | Indianapolis | Indiana | 46202 | — |
| US105 | Lexington | Kentucky | 40536 | — |
| US130 | Quincy | Massachusetts | 02196 | — |
| US102 | Rochester | Minnesota | 55905 | — |
| US109 | New York | New York | 10032 | — |
| US100 | Chapel Hill | North Carolina | 27514 | — |
| US110 | Cleveland | Ohio | 44195 | — |
| US106 | Columbus | Ohio | 43210 | — |
| US131 | Portland | Oregon | 97210 | — |
| US120 | Willow Grove | Pennsylvania | 19090 | — |
| US101 | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02928445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2018 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02928445 live on ClinicalTrials.gov.